Any focus on the cost of treatment is incredibly misguided when it comes to personalised medicines because it belies the reality of what they will provide - governments will be paying for less failure and the potential for cures will mean patients will be treated with fewer therapies. …
What happens when the government is paying for less failure?
August 7, 2019 Latest NewsNews of the Day
Latest Video
New Stories
-
The 'post-rebate' era has started with or without supply chain reform
August 23, 2019 - - Latest News -
Is there even a plan for emerging therapies in Australia?
August 23, 2019 - - Latest News -
Federal government still finalising CAR-T agreement with Peter Mac
August 23, 2019 - - Latest News -
EBOS looking to 'the next wave of growth'
August 23, 2019 - - Latest News -
Bayer makes another move into cell therapy
August 22, 2019 - - Latest News -
Government could come for more given savings shortfall
August 22, 2019 - - Latest News -
Patients might be hoping their medicine belongs to a large company
August 22, 2019 - - Latest News